Original Research: Risk Factors for Mortality from Primary Cryptococcosis in Patients with HIV

References

• . Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis: a study in 111 cases. Ann Intern Med. 1974;80(2):176–181
   PubMed Web of Science ®Google Scholar
• . White M, Cirrincione C, Blevins A, Armstrong D. Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. J Infect Dis. 1992;165(5):960–963
   PubMed Web of Science ®Google Scholar
• . Saag MS, Powderly WG, Cloud GA,. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med. 1992;326(2):83–89
   PubMed Web of Science ®Google Scholar
• . Van der horst CM, Saag MS, Cloud GA,. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med. 1997;337(1):15–21
   PubMed Web of Science ®Google Scholar
• . Graybill JR, Sobel J, Saag MS,. Diagnosis and managment of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis. 2000;30(1):47–54
   PubMed Web of Science ®Google Scholar
• . Saag MS, Graybill RJ, Larsen RA,. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis. 2000;30(4):710–718
   PubMed Web of Science ®Google Scholar
• . Jarvis JN, Harrison TS. HIV-associated cryptococcal meningitis. AIDS. 2007;21(16):2119–2129
   PubMed Web of Science ®Google Scholar
• . Dromer F, Mathoulin-Pélissier S, Launay O, Lortholary O; French Cryptococcosis Study Group. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med. 2007;4(2):e21
   PubMed Web of Science ®Google Scholar
• . Dromer F, Mathoulin-Pélissier S, Fontanet A, Ronin O, Dupont B, Lortholary O; French Cryptococcosis Study Group. Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras. AIDS. 2004;18(3):555–562
   PubMed Web of Science ®Google Scholar
• . Mirza SA, Phelan M, Rimland D,. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992–2000. Clin Infect Dis. 2003;36(6):789–794
   PubMed Web of Science ®Google Scholar
• . Pukkila-Worley R, Mylonakis E. Epidemiology and management of cryptococcal meningitis: developments and challenges. Expert Opin Pharmacother. 2008;9(4):551–560
   PubMed Web of Science ®Google Scholar
• . Brouwer AE, Rajanuwong A, Chierakul W,. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet. 2004;363(9423):1764–1767
   PubMed Web of Science ®Google Scholar
• . Khawcharoenporn T, Apisarnthanarak A, Mundy LM. Treatment of cryptococcosis in the setting of HIV coinfection. Expert Rev Anti Infect Ther. 2007;5(6):1019–1013
   PubMed Web of Science ®Google Scholar
• . Bicanic T, Wood R, Meintjes G,. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Clin Infect Dis. 2008;47(1):123–130
   PubMed Web of Science ®Google Scholar
• . Powderly WG. Editorial commentary: dosing amphotericin B in cryptococcal meningitis. Clin Infect Dis. 2008;47(1):131–132
   PubMed Web of Science ®Google Scholar
• . Kambugu A, Meya DB, Rhein J,. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis. 2008;46(11):1694–1670
   PubMed Web of Science ®Google Scholar
• . Asawavichienjinda T, Sitthi-Amorn C, Tanyanont V. Serum cyrptococcal antigen: diagnostic value in the diagnosis of AIDS-related cryptococcal meningitis. J Med Assoc Thai. 1999;82(1):65–71
   PubMedGoogle Scholar
• . Cheng VC, Yuen KY, Chan WM, Wong SS, Ma ES, Chan RM. Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis. 2000;30(6):882–892
   PubMed Web of Science ®Google Scholar
• . French MA, Lenzo N, John M, Mallal SA,. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med. 2000;1(2):107–115
   PubMedGoogle Scholar
• . Shelburne SA, Hamill RJ, Rodriguez-Barradas MC,. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine. 2002;81(3):213–227
   PubMed Web of Science ®Google Scholar
• . Cooney EL. Clinical indicators of immune restoration following highly active antiretroviral therapy. Clin Infect Dis. 2002;34(2):224–233
   PubMed Web of Science ®Google Scholar
• . Jenny-Avital ER, Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis. 2002;35(12):e128–e133
   PubMed Web of Science ®Google Scholar
• . French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS. 2004;18(12):1615–1627
   PubMed Web of Science ®Google Scholar
• . Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis. 2004;38(8):1159–1166
   PubMed Web of Science ®Google Scholar
• . Shelburne SA, Visnegarwala F, Darcourt J,. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005;19(4):399–406
   PubMed Web of Science ®Google Scholar
• . Gray F, Bazille C, Adle-Biassette H, Mikol J, Moulignier A, Scaravilli F. Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol. 2005;11( suppl 3):16–22
   PubMed Web of Science ®Google Scholar
• . Broom J, Woods M 2nd, Allworth A. Immune reconstitution inflammatory syndrome producing atypical presentations of cryptococcal meningitis: case report and a review of immune reconstitution-associated cryptococcal infections. Scand J Infect Dis. 2006;38(8):219–221
   PubMedGoogle Scholar
• . Lipman M, Breen R. Immune reconstitution inflammatory syndrome in HIV. Curr Opin Infect Dis. 2006;19(1):20–25
   PubMed Web of Science ®Google Scholar
• . Shelburne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother. 2006;57(2):167–170
   PubMed Web of Science ®Google Scholar
• . Sungkanuparph S, Jongwutiwes U, Kiertiburanakul S. Timing of cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in patients with AIDS and cryptococcal meningitis. J Acquir Immune Defic Syndr. 2007;45(5):595–596
   PubMed Web of Science ®Google Scholar
• . Charlier C, Dromer F, Leveque C,; French Cryptococcosis Study Group. Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era. PloS One. 2008;3:e1950
   PubMed Web of Science ®Google Scholar
• . Meyohas MC, Roux P, Bollens D,. Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis. 1995;21(3):628–633
   PubMed Web of Science ®Google Scholar
• . Cameron M, Bartlett JA, Galiis HA, Waskiin HA. Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome. Rev Infect Dis. 1991;13(1):64–67
   PubMedGoogle Scholar
• . Shoham S, Cover C, Donegan N, Fulnecky E, Kumar P. Cryptococcus neoformans meningitis at 2 hospitals in Washington, DC: adherence of health care providers to published practice guidelines for the management of cryptococcal disease. Clin Infect Dis. 2005;40(3):477–479
   PubMed Web of Science ®Google Scholar
• . Rogers FB, Shackford SR, Trevisani GT, Davis JW, Mackersie RC, Hoyt DB. Neurogenic pulmonary edema in fatal and nonfatal head injuries. J Trauma. 1995;39(5):860–866
   PubMedGoogle Scholar
• . Sedý J, Zicha J, Kuneš J, Jendelová P, Syková E. Mechanisms of neurogenic pulmonary edema development. Physiol Res. 2008;57(4):499–506
   PubMed Web of Science ®Google Scholar